Andrzej Budaj-rekin lankidetzan egindako argitalpenak (4)

2016

  1. Cardiovascular and other outcomes postintervention with insulin glargine and omega-3 fatty acids (ORIGINALE)

    Diabetes Care, Vol. 39, Núm. 5, pp. 709-716

2012

  1. Basal insulin and cardiovascular and other outcomes in dysglycemia

    New England Journal of Medicine, Vol. 367, Núm. 4, pp. 319-328

  2. N-3 fatty acids and cardiovascular outcomes in patients with dysglycemia

    New England Journal of Medicine, Vol. 367, Núm. 4, pp. 309-318

2008

  1. Rationale, design, and baseline characteristics for a large international trial of cardiovascular disease prevention in people with dysglycemia: The ORIGIN Trial (Outcome Reduction with an Initial Glargine Intervention)

    American Heart Journal, Vol. 155, Núm. 1, pp. 26.e1-26.e13